P.838Coronavirus information to psychiatric patients
Autor: | Ana Giurgiuca, I. Dutu, R. Alina, Valentin Petre Matei, C. Tudose, A. Pavel, R. Grigoras, S. Arina |
---|---|
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19) Population Clinical Neurology 03 medical and health sciences 0302 clinical medicine Internal medicine Health care medicine Psychiatric hospital Pharmacology (medical) education Biological Psychiatry Pharmacology education.field_of_study business.industry Cognition Mental illness medicine.disease 030227 psychiatry Psychiatry and Mental health Neurology Male patient Mann–Whitney U test Neurology (clinical) business 030217 neurology & neurosurgery |
Zdroj: | European Neuropsychopharmacology |
ISSN: | 0924-977X |
Popis: | Background: While the Coronavirus-19 pandemic is apparently receding, a second wave is still well possible Patients diagnosed with a severe mental illness (SMI) have an excess mortality and their lifespan is between 10 to 30 years shorter compared to general population [1] There are also discrepancies in healthcare access and its utilization in patients with SMI compared to general population [2] People with SMI are more vulnerable to infectious diseases What is more, Cov19 mortality seems to be double in males compared to females [3] Therefore, male SMI patients represent a particularly vulnerable group susceptible to both Cov-19 infection and a severe course of illness Aims: Our study aims to examine the level of information regarding the new Coronavirus-19 in SMI patients compared to general population Methods: We applied two questionnaires to male patients with severe mental illness One of the them was based on the five important affirmations from WHO [4] There were two possible answers for each question, true or false, with a maximum score of 5 points for each questionnaire The higher the score, the better the knowledge of preventive measures against infection with coronavirus Our sample consisted of 42 male inpatients from “Alexandru Obregia Psychiatric Hospital” admitted between March and June 2020 and 42 controls matched by gender, age and education Prior to filling the questionnaires, patients did not receive any formal information or education upon this topic, other than the instructions from the media Scores were compared using Mann Whitney test and results were considered statistically significant al alpha 0 05,2-tailed Results: Mean and median scores for the questions evaluating general information were: 6 95 (±1 75) and 7 (IQR 6-8 25) for SMI patients and 9 07 (±1 46) and 10 (IQR 8 75-10) for controls (U=315, Z=-5 21, p< 001) Mean and median scores for level of knowledge about WHO prevention measures were and 4 38 (±0 96) and 5 (IQR 4-5) for SMI patients and 4 76 (±0 62) and 5 (IQR 5-5) for controls (U=685 5, Z=2 25, p= 025) For fictitious information about COVID-19, SMI patients had a mean score of 2 52 (±1 63) and a median one of 3 (IQR 1-4) while controls had 4 33 (±1 16) and a median of 5 (IQR 4-5) (U=324, Z=-5 19, p< 001) Conclusion: To our best knowledge this is the first study evaluating Cov-10 information in SMI patients Patients with SMI had a lower knowledge of prevention methods against coronavirus There are multiple factors that can contribute to these results as the severity of the pathology, cognitive capacities, insight and it might be possible that some patients do not understand simple statements In addition, the SMI group was less likely to discern erroneous information from genuine advice For this matter, traditional ways of offering information to SMI patients may need altering and personalization since is of vital importance for infectious prevention and spreading of the virus No conflict of interest |
Databáze: | OpenAIRE |
Externí odkaz: |